Natural Products Insider is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


NPA CEO Discusses Regulatory Status of Kratom

Dan Fabricant Expo West
In this short video, former FDA official Daniel Fabricant, Ph.D., weighs in on kratom, the popular and controversial botanical.

At Natural Products Expo West, we asked the head of the Natural Products Association (NPA)—Daniel Fabricant, Ph.D.—about kratom, a popular and controversial botanical targeted in recent warning letters by his former employer, FDA. Hear what Fabricant had to say about regulatory issues surrounding kratom in the United States, including claims about its ability to help people addicted to opioids.

This is the second in a three-part video series based on a wide-ranging interview with Fabricant at Expo West, which was held in March in Anaheim, California.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.